Peer-reviewed articles

O’Brien KM, Sharp L. Trends in incidence of, and mortality from, cervical lesions in Ireland: Baseline data for future evaluation of the national cervical screening programme. Cancer Epidemiol. Published online October 12, 2013. doi:10.1016/j.canep.2013.09.002

McDevitt J, Kelly M, Comber H, Kelleher T, Dwane F, Sharp L. A population-based study of hospital length of stay and emergency readmission following surgery for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44(4):e253-259. doi:10.1093/ejcts/ezt389

Drummond FJ, Barrett E, Burns R, O’Neill C, Sharp L. The number of tPSA tests continues to rise and variation in testing practices persists: a survey of laboratory services in Ireland 2008-2010. Ir J Med Sci. Published online September 27, 2013. doi:10.1007/s11845-013-1022-y

Barron TI, Cahir C, Sharp L, Bennett K. A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer. Br J Cancer. 2013;109(6):1513-1521. doi:10.1038/bjc.2013.518

Naidoo J, Teo MY, Deady S, Comber H, Calvert P. Should Patients with Extrapulmonary Small-Cell Carcinoma Receive Prophylactic Cranial Irradiation?: Journal of Thoracic Oncology. 2013;8(9):1215-1221. doi:10.1097/JTO.0b013e31829f6b03

O’Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci. Published online August 17, 2013. doi:10.1007/s11845-013-0993-z

Spillane S, Bennett K, Sharp L, Barron TI. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(8):1364-1373. doi:10.1158/1055-9965.EPI-13-0347

de Camargo Cancela M, Comber H, Sharp L. Hospital and surgeon caseload are associated with risk of re-operation following breast-conserving surgery. Breast Cancer Res Treat. 2013;140(3):535-544. doi:10.1007/s10549-013-2652-5

Arnold M, Holterhues C, Hollestein LM, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. Journal of the European Academy of Dermatology and Venereology. 2013;28(9):1170-1178. doi:10.1111/jdv.12236

White C, Keegan H, Pilkington L, et al. Evaluation of the clinical performance of the cobas® 4800 HPV test in a colposcopy referred population. J Clin Microbiol. 2013;51(10):3415-3417. doi:10.1128/JCM.01949-13

de Camargo Cancela M, Comber H, Sharp L. Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study. Br J Cancer. 2013;109(1):272-279. doi:10.1038/bjc.2013.268

Kelly M, Sharp L, Dwane F, Kelleher T, Drummond FJ, Comber H. Factors predicting hospital length-of-stay after radical prostatectomy: a population-based study. BMC Health Serv Res. 2013;13(1):244. doi:10.1186/1472-6963-13-244

Flahavan EM, Sharp L, Bennett K, Barron TI. A cohort study of digoxin exposure and mortality in men with prostate cancer. BJU Int. Published online June 13, 2013. doi:10.1111/bju.12287

Skally M, Hanly P, Sharp L. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature. Appl Health Econ Health Policy. 2013;11(3):181-192. doi:10.1007/s40258-013-0010-8

Hanly P, Céilleachair AO, Skally M, et al. Time costs associated with informal care for colorectal cancer: an investigation of the impact of alternative valuation methods. Appl Health Econ Health Policy. 2013;11(3):193-203. doi:10.1007/s40258-013-0013-5

Hanly P, Céilleachair AO, Skally M, et al. How much does it cost to care for survivors of colorectal cancer? Caregiver’s time, travel and out-of-pocket costs. Support Care Cancer. Published online May 7, 2013. doi:10.1007/s00520-013-1834-3

Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013;22(4):745-755. doi:10.1002/pon.3055

Ó Céilleachair AJ, Hanly P, Skally M, et al. Cost comparisons and methodological heterogeneity in cost-of-illness studies: the example of colorectal cancer. Med Care. 2013;51(4):339-350. doi:10.1097/MLR.0b013e3182726c13

McDevitt J, Sharp L, MacDonald D, Dwane F, Comber H. Factors affecting receipt of a medical card in a cohort of colorectal cancer patients, 2002-2006. Ir Med J. 2013;106(4):110-113.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-1403. doi:10.1016/j.ejca.2012.12.027

Sharp L, Walsh C, Whyte S, et al. Reply: cost-effectiveness of population-based screening for colorectal cancer. Br J Cancer. 2013;108(5):1211-1212. doi:10.1038/bjc.2012.491

Maynadie M, De Angelis R, Marcos-Gragera R, et al. Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica. 2013;98(2):230-238. doi:10.3324/haematol.2012.064014

Sharp L, Cotton S, Carsin AE, et al. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psychooncology. 2013;22(2):368-380. doi:10.1002/pon.2097

Hanly P, Walsh PM, O Céilleachair A, et al. Work-related productivity losses in an era of ageing populations: the case of colorectal cancer. J Occup Environ Med. 2013;55(2):128-134. doi:10.1097/JOM.0b013e3182820553

Bennett M, Comber H, Deady S. Incidence of nonmelanoma skin cancer in Ireland. Br J Dermatol. 2013;168(2):452. doi:10.1111/j.1365-2133.2012.11172.x